Check Out What Whales Are Doing With MRNA

Check Out What Whales Are Doing With MRNA

Someone with a lot of money to spend has taken a bearish stance on Moderna MRNA.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 21 uncommon options trades for Moderna.

This isn't normal.

The overall sentiment of these big-money traders is split between 42% bullish and 57%, bearish.

Out of all of the special options we uncovered, 12 are puts, for a total amount of $467,271, and 9 are calls, for a total amount of $497,457.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $110.0 to $470.0 for Moderna over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $110.0 to $470.0 in the last 30 days.

Moderna Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:


Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRNA CALL TRADE BULLISH 11/18/22 $140.00 $111.0K 407 39
MRNA CALL TRADE BEARISH 06/16/23 $115.00 $105.7K 30 16
MRNA PUT SWEEP BULLISH 10/07/22 $126.00 $87.4K 56 93
MRNA CALL TRADE BULLISH 04/21/23 $145.00 $64.6K 663 44
MRNA CALL TRADE BULLISH 10/21/22 $125.00 $45.9K 584 352

Where Is Moderna Standing Right Now?

  • With a volume of 2,240,585, the price of MRNA is up 1.51% at $120.04.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 31 days.

What The Experts Say On Moderna:

  • Argus Research has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $150.
  • Deutsche Bank upgraded its action to Buy with a price target of $165

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.

Posted In: BZI-UOAOptionsMarkets